Company Quick10K Filing
Albemarle
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 106 $7,392
10-Q 2019-11-06 Quarter: 2019-09-30
10-Q 2019-08-07 Quarter: 2019-06-30
10-Q 2019-05-08 Quarter: 2019-03-31
10-K 2019-02-27 Annual: 2018-12-31
10-Q 2018-11-07 Quarter: 2018-09-30
10-Q 2018-08-07 Quarter: 2018-06-30
10-Q 2018-05-10 Quarter: 2018-03-31
10-K 2018-02-28 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-09-30
10-Q 2017-08-08 Quarter: 2017-06-30
10-Q 2017-05-04 Quarter: 2017-03-31
10-K 2017-02-28 Annual: 2016-12-31
10-Q 2016-11-08 Quarter: 2016-09-30
10-Q 2016-08-05 Quarter: 2016-06-30
10-Q 2016-05-10 Quarter: 2016-03-31
10-K 2016-02-29 Annual: 2015-12-31
10-Q 2015-11-06 Quarter: 2015-09-30
10-Q 2015-08-07 Quarter: 2015-06-30
10-Q 2015-05-11 Quarter: 2015-03-31
10-K 2015-03-02 Annual: 2014-12-31
10-Q 2014-10-29 Quarter: 2014-09-30
10-Q 2014-07-31 Quarter: 2014-06-30
10-Q 2014-04-24 Quarter: 2014-03-31
10-K 2014-02-25 Annual: 2013-12-31
10-Q 2013-10-18 Quarter: 2013-09-30
10-Q 2013-07-19 Quarter: 2013-06-30
10-Q 2013-04-19 Quarter: 2013-03-31
10-Q 2012-10-19 Quarter: 2012-09-30
10-Q 2012-07-19 Quarter: 2012-06-30
10-Q 2012-04-19 Quarter: 2012-03-31
10-K 2012-02-22 Annual: 2011-12-31
10-Q 2011-10-25 Quarter: 2011-09-30
10-Q 2011-07-26 Quarter: 2011-06-30
10-Q 2011-04-28 Quarter: 2011-03-31
10-K 2011-02-25 Annual: 2010-12-31
10-Q 2010-10-29 Quarter: 2010-09-30
10-Q 2010-08-06 Quarter: 2010-06-30
10-Q 2010-05-07 Quarter: 2010-03-31
10-K 2010-02-26 Annual: 2009-12-31
8-K 2019-11-25 Off-BS Arrangement, Other Events, Exhibits
8-K 2019-11-06 Earnings, Exhibits
8-K 2019-10-31 Enter Agreement, M&A, Off-BS Arrangement, Regulation FD, Other Events, Exhibits
8-K 2019-10-28 Officers
8-K 2019-10-24 Earnings, Exhibits
8-K 2019-08-14 Enter Agreement, Off-BS Arrangement
8-K 2019-08-07 Earnings, Exhibits
8-K 2019-08-01 Enter Agreement
8-K 2019-07-23 Officers, Amend Bylaw, Exhibits
8-K 2019-05-08 Earnings, Exhibits
8-K 2019-05-07 Shareholder Vote
8-K 2019-02-20 Earnings, Exhibits
8-K 2018-12-14 Enter Agreement
8-K 2018-11-07 Earnings, Exhibits
8-K 2018-08-09 Regulation FD
8-K 2018-08-07 Earnings, Exhibits
8-K 2018-06-21 Enter Agreement, Leave Agreement, Off-BS Arrangement
8-K 2018-05-14 Regulation FD
8-K 2018-05-09 Earnings, Exhibits
8-K 2018-05-08 Shareholder Vote
8-K 2018-03-12
8-K 2018-02-27 Earnings, Exhibits
8-K 2018-02-23 Officers
8-K 2018-01-17 Officers, Exhibits

Albemarle Financials

ALB Metrics, Comps, Filings

Annual | Quarterly

Business

Albemarle Corporation was incorporated in Virginia in 1993. Our principal executive offices are located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209. Unless the context otherwise indicates, the terms "Albemarle," "we," "us," "our" or "the Company" mean Albemarle Corporation and its consolidated subsidiaries.

We are a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals that are designed to meet our customers' needs across a diverse range of end markets. The end markets we serve include energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection and custom chemistry services. We believe that our commercial and geographic diversity, technical expertise, innovative capability, flexible, low-cost global manufacturing base, experienced management team and strategic focus on our core base technologies will enable us to maintain leading market positions in those areas of the specialty chemicals industry in which we operate.

We and our joint ventures currently operate 29 production and research and development ("R&D") facilities, as well as a number of administrative and sales offices, around the world. As of December 31, 2018, we served approximately 2,300 customers, none of which individually represents more than 10% of net sales of the Company, in approximately 100 countries. For information regarding our unconsolidated joint ventures see Note 10, "Investments," to our consolidated financial statements included in Part II, Item 8 of this report.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
FMC (FMC) 10,857 45% 16.9 5% 9,824 7,061 4,653 2,083 503 787 13,305
Eastman Chemical (EMN) 10,762 24% 9.4 6% 16,256 10,310 9,666 2,357 915 1,724 16,200
Westlake Chemical (WLK) 8,701 18% 6.7 5% 12,216 5,957 8,419 1,532 660 1,640 10,985
Albemarle (ALB) 7,392 35% 9.7 7% 8,094 4,294 3,417 1,210 600 914 8,883
Hexcel (HXL) 6,722 27% 16.5 7% 3,195 1,753 2,320 629 219 473 7,792
Sealed Air (SEE) 6,537 32% 13.4 7% 5,216 5,558 4,720 1,508 370 718 9,606
Versum Materials (VSM) 5,704 42% 20.8 6% 1,459 1,255 1,341 569 86 309 6,416
WR Grace (GRA) 5,061 40% 16.0 5% 3,726 3,339 1,998 796 186 430 6,861
NewMarket (NEU) 4,509 28% 11.9 15% 1,767 1,178 2,202 606 258 429 5,114
Huntsman (HUN) 4,457 20% 14.9 -1% 8,896 6,220 8,908 1,761 -74 470 6,986
Chemours (CC) 4,249 25% 6.6 8% 7,433 6,604 5,876 1,496 607 1,184 7,868
Ingevity (NGVT) 4,073 37% 19.1 8% 2,130 1,729 1,219 448 173 283 5,412
Valvoline (VVV) 3,610 34% 17.0 11% 2,000 2,252 2,355 796 226 284 4,814
Olin (OLN) 3,566 15% 5.7 3% 9,235 6,464 6,654 1,010 270 1,212 6,855
Balchem (BCPC) 3,264 32% 21.4 7% 1,098 366 637 202 78 150 3,223
Sensient Technologies (SXT) 3,037 0% 14.8 8% 1,825 928 1,359 0 147 247 3,664
Rogers (ROG) 2,945 35% 16.8 7% 1,307 410 932 329 97 177 2,968
Platform Specialty Products (PAH) 2,714 43% -10.7 -9% 4,440 2,209 1,883 803 -395 -377 4,040
Cabot (CBT) 2,692 22% 7.4 8% 3,119 2,027 3,360 727 248 488 3,622
Quaker Chemical (KWR) 2,664 36% 29.2 8% 725 267 851 307 57 88 2,569

Balance Sheet ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash53046947847702142,2701,137555
Accounts Receivable3413553794470553486534606
Inventory389431428436-14509450593701
PP&E1,0061,1291,2971,35702,4852,3602,4933,021
Assets3,0683,2043,4373,585-1,6629,6158,1617,7517,582
Accounts Payable1751841731940307282419523
Long-Term Debt861416871,054193,8522,3691,8371,705
Liabilities1,6521,6131,6041,957-926,3614,3664,0763,996
Stockholders' Equity1,4161,5911,8341,627-1,5703,2543,7953,6753,585
Income Statement ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue2,3632,8692,7452,616-6863,6512,6773,0723,375
Cost of Revenue1,6171,8921,8351,755-6902,4541,7071,9622,158
Gross Profit74697791086141,1979711,1101,217
R&D587779820103808470
SG&A2663123131630512380438446
Tax931308313656162143432145
Net Income337464330440-10436068199739
Cash Flow ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating331487489433-8361733304546
Cash Investing-92-213-301-1580-2,1612,920-358-304
Cash Financing-8-329-177-2888-478-1,578-1,087-787